Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
December 18 Product: Celltrions Steqeyma Indication: Plaque psoriasis and psoriatic arthritis in adults and children, Crohns disease and ulcerative colitis in adults Johnson & Johnson will face even stiffer competition for its blockbuster immunotherapy Stelara (ustekinumab) after the FDA on Wednesday signed off on Celltrions biosimilar Steqeyma
The first is how effective it is at what it does, and the second is how few side effects there are for the vast majority of people
Eli Lilly said in an open letter that it was "deeply concerned" about growing online sales and social media posts involving phony or compounded versions of tirzepatide, the active ingredient behind its drugs Mounjaro and Zepbound
Feb 3, 2026 Somewhere inside a damaged neuron, a cascade of molecular signals is failing
If you would like to report to the FDA a side effect youve had with Farxiga, you can do so through MedWatch
US$ 25.44
US$ 28.64
US$ 29.46
